Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Global Trend, Demand, Scope, Growth Analysis And Industry Forecast 2020-2030

The Business Research Company offers "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020-30: COVID 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global lateral flow immunoassay based rapid test market is expected to decline from $5.98 billion in 2019 to $5.77 billion in 2020 at a compound annual growth rate (CAGR) of -3.63%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.54 billion in 2023 at a CAGR of 9.36%.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3293

The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop lateral flow immunoassays (LFIA) based rapid test equipment. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples obtained from the human body or animals, or pollutants in water sources, food or animal feed.

The demand for point-of-care testing under home care settings is expected to drive the Lateral Flow Immunoassay (LFIA) Based Rapid Test market. Point-of-care (POCT) testing is essential for rapid on-site diagnosis and treatment. The most important features for current POCT diagnostic systems are a quick analysis time with a test-to-answer format. Lateral flow immunoassays (LFIA) are widely used as POCTs due to their speed and precision, simplicity and low cost. For instance, the recent outbreak of coronavirus disease (COVID-19) has increased the significance of these devices to rapid screening and surveillance. Acro Biotech COVID-19 Rapid POC CE-IVD is a lateral flow immunoassay that quantifiably assesses the existence of patient-generated IgG and IgM antibodies to SARS-CoV-2, the causative agent of novel coronaviral disease COVID-19.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation: -
By Technique
Competitive Assay
Sandwich Assay
Multiplex Detection Assay

By End User
Hospital and Clinic
Diagnostic Laboratory
Home Care
Others

By Application
Infectious Disease
Pregnancy and Fertility
Toxicology
Others

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics
3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size And Growth
4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation
5. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis
.
.
.
25. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
27. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies
28. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp

Some of the key players involved in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market are Abbott Laboratories, F. Hoffmann-La Roche, Danaher Corporation, Siemens AG, Becton, Dickinson and Company.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.